ArticleScientific reports2025
PCL scaffold with well-defined hierarchical pores effectively controls cell migration and alignment of human mesenchymal stem cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Advances in extrusion-based bioprinting enabled by advanced printhead and nozzle designs.Materials today. Bio · 2026Review
- Mastoid Obliteration After Canal Wall Down Mastoidectomy Using Tissue Engineering Approaches with Polymers, Mesenchymal Stem Cells, and Bioactive Molecules: A Systematic Review.Bioengineering (Basel, Switzerland) · 2026Review
- Research advances in early diagnosis and treatment strategies for peri-implantitis: from microecology to regenerative therapy.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
With an increasing incidence of orthopedic fractures due to the growing aging population, the demand for novel bone tissue engineering treatments is rising. Existing biopolymeric scaffolds have hierarchical structure, are biocompatible, and are biodegradable, but struggle to control pore size and interconnectivity, essential features to regulate cell alignment and mechanobiological signaling. This highlights the need to design a biopolymeric scaffold with well-defined hierarchical structure and optimized surface properties to improve bone regeneration. To accomplish this, we proposed a grid-in-grid manufacturing approach and fabricated a solvent-free 3D polycaprolactone (PCL) scaffold with hierarchical pores using precision extruding deposition (PED) 3D printing technology. The fabricated scaffolds exhibit both global pores and multi-scale local pores. Notably, using in vitro cultured human mesenchymal stem cells (hMSCs), controlled local pore size induced contact guidance and pore bridging, and the surface roughness of global strands effectively led to cell alignment. This study demonstrates that precision 3D printing technology can directly manipulate local pore structures to control cell migration and alignment. Furthermore, it could be applied for combined bone to connective tissue regeneration, where gradient pore structures and cell alignment are essential. Our scaffold has the potential to serve as a customizable platform for advanced tissue engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.